These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 9533420)
21. Effect of sympathectomy on arterial and venous changes in renal hypertensive rats. Simon G Am J Physiol; 1981 Sep; 241(3):H449-54. PubMed ID: 7282954 [TBL] [Abstract][Full Text] [Related]
22. Angiotensin II induces vascular dysfunction without exacerbating blood pressure elevation in a mouse model of menopause-associated hypertension. Javeshghani D; Sairam MR; Neves MF; Schiffrin EL; Touyz RM J Hypertens; 2006 Jul; 24(7):1365-73. PubMed ID: 16794486 [TBL] [Abstract][Full Text] [Related]
23. Angiotensin II induces vascular smooth muscle cell replication independent of blood pressure. Su EJ; Lombardi DM; Siegal J; Schwartz SM Hypertension; 1998 Jun; 31(6):1331-7. PubMed ID: 9622150 [TBL] [Abstract][Full Text] [Related]
24. Involvement of prolylcarboxypeptidase in the effect of rutaecarpine on the regression of mesenteric artery hypertrophy in renovascular hypertensive rats. Qin XP; Zeng SY; Tian HH; Deng SX; Ren JF; Zheng YB; Li D; Li YJ; Liao DF; Chen SY Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):319-24. PubMed ID: 19018804 [TBL] [Abstract][Full Text] [Related]
25. Time-dependent changes in autonomic control of splanchnic vascular resistance and heart rate in ANG II-salt hypertension. Kuroki MT; Guzman PA; Fink GD; Osborn JW Am J Physiol Heart Circ Physiol; 2012 Feb; 302(3):H763-9. PubMed ID: 22114134 [TBL] [Abstract][Full Text] [Related]
26. Role of renal nerves in afferent arteriolar reactivity in angiotensin-induced hypertension. Ichihara A; Inscho EW; Imig JD; Michel RE; Navar LG Hypertension; 1997 Jan; 29(1 Pt 2):442-9. PubMed ID: 9039140 [TBL] [Abstract][Full Text] [Related]
27. Bosentan prevents preglomerular alterations during angiotensin II hypertension. Casellas D; Bouriquet N; Herizi A Hypertension; 1997 Dec; 30(6):1613-20. PubMed ID: 9403591 [TBL] [Abstract][Full Text] [Related]
28. Neonatal chemical sympathectomy attenuates fructose-induced hypertriglyceridemia and hypertension in rats. Hsieh PS; Huang WC Chin J Physiol; 2001 Mar; 44(1):25-31. PubMed ID: 11403517 [TBL] [Abstract][Full Text] [Related]
29. Inhibition of mitogen-activated protein/extracellular signal-regulated kinase improves endothelial function and attenuates Ang II-induced contractility of mesenteric resistance arteries from spontaneously hypertensive rats. Touyz RM; Deschepper C; Park JB; He G; Chen X; Neves MF; Virdis A; Schiffrin EL J Hypertens; 2002 Jun; 20(6):1127-34. PubMed ID: 12023682 [TBL] [Abstract][Full Text] [Related]
31. Small artery mechanics in hyperhomocysteinemic mice: effects of angiotensin II. Neves MF; Endemann D; Amiri F; Virdis A; Pu Q; Rozen R; Schiffrin EL J Hypertens; 2004 May; 22(5):959-66. PubMed ID: 15097236 [TBL] [Abstract][Full Text] [Related]
32. Angiotensin II-induced hypertension is associated with a selective inhibition of endothelium-derived hyperpolarizing factor-mediated responses in the rat mesenteric artery. Dal-Ros S; Bronner C; Schott C; Kane MO; Chataigneau M; Schini-Kerth VB; Chataigneau T J Pharmacol Exp Ther; 2009 Feb; 328(2):478-86. PubMed ID: 18984652 [TBL] [Abstract][Full Text] [Related]
33. Effects of glitazones on blood pressure and vascular structure in mesenteric resistance arteries and basilar artery from genetically hypertensive rats. Ledingham JM; Laverty R Clin Exp Pharmacol Physiol; 2005 Nov; 32(11):919-25. PubMed ID: 16405447 [TBL] [Abstract][Full Text] [Related]
34. TIMP3 is the primary TIMP to regulate agonist-induced vascular remodelling and hypertension. Basu R; Lee J; Morton JS; Takawale A; Fan D; Kandalam V; Wang X; Davidge ST; Kassiri Z Cardiovasc Res; 2013 Jun; 98(3):360-71. PubMed ID: 23524300 [TBL] [Abstract][Full Text] [Related]
35. Sympathetic nerves and the progression of chronic kidney disease during 5/6 nephrectomy: studies in sympathectomized rats. Augustyniak RA; Picken MM; Leonard D; Zhou XJ; Zhang W; Victor RG Clin Exp Pharmacol Physiol; 2010 Jan; 37(1):12-8. PubMed ID: 19566818 [TBL] [Abstract][Full Text] [Related]
36. Renovascular remodeling and renal injury after extended angiotensin II infusion. Casare FA; Thieme K; Costa-Pessoa JM; Rossoni LV; Couto GK; Fernandes FB; Casarini DE; Oliveira-Souza M Am J Physiol Renal Physiol; 2016 Jun; 310(11):F1295-307. PubMed ID: 26962104 [TBL] [Abstract][Full Text] [Related]
37. Regulation of vascular type 1 angiotensin II receptor in hypertension and sodium loading: role of angiotensin II. Wang DH; Du Y J Hypertens; 1998 Apr; 16(4):467-75. PubMed ID: 9797192 [TBL] [Abstract][Full Text] [Related]
38. Selective increase in renal arcuate innervation density and neurogenic constriction in chronic angiotensin II-infused rats. Parkington HC; Dodd J; Luff SE; Worthy K; Coleman HA; Tare M; Anderson WP; Edgley AJ Hypertension; 2004 Mar; 43(3):643-8. PubMed ID: 14757774 [TBL] [Abstract][Full Text] [Related]
39. ET(A) receptor antagonist prevents blood pressure elevation and vascular remodeling in aldosterone-infused rats. Park JB; Schiffrin EL Hypertension; 2001 Jun; 37(6):1444-9. PubMed ID: 11408393 [TBL] [Abstract][Full Text] [Related]
40. Role of angiotensin II, sympathetic stimulation and salt in the development of structural vascular changes in rat kidney. Simon G; Jäckel M; Illyes G Clin Exp Pharmacol Physiol; 2003 Jul; 30(7):476-81. PubMed ID: 12823262 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]